Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss BMA Q4 2025 Earnings Strong EPS Beat Amidst Mixed Market Reaction UTSI Q4 2019 Earnings Significant EPS Miss Sends Stock Down Sera Prognostics Q1 2026 Earnings EPS Matches Estimates Stock Surges 15 on Strategic Progress ASAN Q1 2026 Earnings Earnings Per Share Beat Estimates Stock Rises 4 PR Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges